Minocycline, then minocycline/lovastatin (DrugBank: Lovastatin, Minocycline)
11 diseases告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
6 | パーキンソン病 | 0 |
34 | 神経線維腫症 | 0 |
46 | 悪性関節リウマチ | 0 |
79 | 家族性高コレステロール血症(ホモ接合体) | 0 |
156 | レット症候群 | 0 |
160 | 先天性魚鱗癬 | 0 |
195 | ヌーナン症候群 | 0 |
206 | 脆弱X症候群 | 1 |
263 | 脳腱黄色腫症 | 0 |
280 | 巨大動静脈奇形(頚部顔面又は四肢病変) | 0 |
310 | 先天異常症候群 | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02680379 (ClinicalTrials.gov) | March 2016 | 25/1/2016 | Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome | A Pilot Study Exploring the Safety and Synergistic Effect of a Minocycline/Lovastatin Combined Treatment on the Behavior of Individuals With Fragile X Syndrome; Validation of New Biochemical and Neurophysiological Markers (LovaMiX) | Fragile X Syndrome | Drug: Minocycline, then Minocycline/Lovastatin;Drug: Lovastatin, then Minocycline/Lovastatin | Université de Sherbrooke | FRAXA Research Foundation | Completed | 8 Years | 45 Years | All | 22 | Phase 2 | Canada |